Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Merck KGaA
  6. News
  7. Summary
    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Merck : Germany's Merck sees boost from labs supplies earnings

05/12/2021 | 01:38am EDT
FILE PHOTO: A logo of drugs and chemicals group Merck KGaA is pictured in Darmstadt

FRANKFURT (Reuters) - Germany's Merck on Wednesday said its Life Science business, a leading maker of biotech lab supplies and gear, saw core earnings jump more than 43% in the first quarter, driven by the pharma industry's efforts to fight the coronavirus pandemic.

Adjusted earnings before interest, tax, depreciation and amortization at the division rose to 793 million euros ($961 million).

The company, which also makes pharmaceuticals and specialty chemicals, on May 4 reported better-than-expected quarterly earnings for the group ahead of schedule.

At the time it said it expected 2021 adjusted earnings before interest, tax, depreciation and amortization (EBITDA) of 5.4-5.8 billion euros, up from 5.2 billion last year. It reaffirmed that guidance on Wednesday.

(Reporting by Ludwig Burger; Editing by Riham Alkousaa)


ę Reuters 2021
All news about MERCK KGAA
03:05aMARKETMIND : Great Q2 but what's next?
RE
02:03aArtios raises USD153m in Series C financing
DJ
01:00aPRESS RELEASE : Organon and ObsEva Enter Global License Agreement to Develop and..
DJ
07/26MARKETMIND : A China crackdown
RE
07/23MERCK KOMMANDITGESELLSCHAFT AUF AKTI : KGaA Appoints China, International Market..
MT
07/23MERCK KGAA : JP Morgan reiterates its Buy rating
MD
07/23MARKETMIND : Lower forever for 'Generation T'?
RE
07/22MERCK : Launches Green Solvents Line for Semiconductor Manufacturers
MT
07/22MARKETMIND : Expect ECB doves to coo
RE
07/22DGAP-PVR : Merck KGaA: Release according to Article 40, Section 1 of the WpHG [t..
DJ
More news
Financials
Sales 2021 18 906 M 22 289 M 22 289 M
Net income 2021 2 580 M 3 041 M 3 041 M
Net Debt 2021 8 920 M 10 515 M 10 515 M
P/E ratio 2021 28,6x
Yield 2021 0,88%
Capitalization 74 717 M 88 244 M 88 084 M
EV / Sales 2021 4,42x
EV / Sales 2022 4,10x
Nbr of Employees 57 850
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 24
Last Close Price 171,85 €
Average target price 155,63 €
Spread / Average Target -9,44%
EPS Revisions
Managers and Directors
BelÚn Garijo Lˇpez Chairman-Executive Board & CEO
Marcus Kuhnert Chief Financial Officer
Wolfgang Heinz BŘchele Chairman-Supervisory Board
Nilesh Kumar Senior Investment Director
Christian Raabe Member-Supervisory Board
Sector and Competitors